Kate Munnings joined Ramsay Health Care as Chief Operating Officer in January 2016 and is responsible for Ramsay’s extensive hospital operations across Australia.
Kate qualified as a registered nurse then later completed a Bachelor of Health Science and a Bachelor of Laws. In 2003, she was appointed as a partner at Corrs Chambers Westgarth, specialising in contract and construction law.
Kate then joined the partnership at Baker McKenzie where she held a number of leadership positions.
In 2006, Kate moved into a corporate role at Transfield Services and was accountable for Legal & Corporate Governance, Risk & Commercial Management, Procurement and Corporate Communication.
Kate was later appointed to the role of Chief Executive of Operations where she had operational responsibility for the Logistics, Construction & Consulting businesses.
Kate has also served as a Board Member for South East Sydney Local Health District for 4 years from 2012 – 2016.
Haryana is a Research Fellow in Cancer Survivorship at the Centre for Medical Psychology and Evidence-based Decision-making (CeMPED) University of Sydney. She is also a member of the Board of the Clinical Oncological Society of Australia (COSA) and Council, and chair of the Survivorship Group of COSA.
Haryana co-leads a Cancer Survivorship Research Group based in the University of Sydney. The group is supported on peer-reviewed funding, allowing studies in cancer and cognition, physical activity in cancer populations, sleep disturbance and symptom control. She also maintains an active research interest in health literacy, communication in the cancer setting and patient education.
Diana Naehrig is a personal development coach and an experienced workshop facilitator.
She has also worked as a doctor, educator and researcher for 18 years, specialising in Radiation Oncology, and more recently Integrative Oncology. Drawing on her medical background, she specialises in the coaching of doctors, health care professionals, early career professionals, researchers and adult students.
In 2018, she has completed a postgraduate Master’s course in Coaching Psychology at the University of Sydney. See CV here.
She has lived, studied and worked in Switzerland, Germany, the USA and Australia.
Fran Boyle is a Medical Oncologist at North Sydney’s Mater Hospital, where she is Director of the Patricia Ritchie Centre for Cancer Care and Research, and Professor of Medical Oncology at the University of Sydney.
She has been involved in clinical trials, supportive care and psychosocial research in breast cancer for the past 20 years. Fran has chaired the Board of Breast Cancer Trials (formerly ANZ Breast Cancer Trials Group) and contributes to clinical trial development nationally and internationally through the BCT and IBCSG. She has recently led the founding of the Metastatic Breast Cancer Alliance in Australia, which promotes the involvement of breast care nurses in the care of patients with metastatic disease, and better access to new therapies.
Fran is a currently a member of the Board of the Breast Cancer Network of Australia, and in 2008 was awarded Membership of the Order of Australia for her contributions to Breast Cancer research, education, policy and advocacy.
Dr Sabe Sabesan graduated with a Bachelor of Medicine and a Bachelor of Surgery from Flinders University in 1995.
He became a fellow of the Royal Australian College of Physicians in 2003. After completing his internship at Alice Springs Hospital in 1996, Dr Sabesan developed a passion for equitable and exceptional patient care regardless of where a person lives. As a result, he pioneered the use of telemedicine at Townsville Hospital to treat patients with cancer who live in remote and rural areas. He is actively involved in research that looks to enhance rural oncology outcomes and has received several grants to support his research and develop systems that better serve rural patients. Dr Sabesan is now a medical oncologist at Icon Townsville and sees patients both on site and via teleconferencing. He is an Associate Professor at James Cook University and is actively involved in curriculum design and coordinating oncology education.
Chief Executive Officer Ramsay Australia
Daniel Sims was appointed the Chief Executive Officer (CEO) of Ramsay Health Care’s Australian operations on 1 January 2015. In Australia, Ramsay Health Care is the leading operator of private hospitals with 63 hospitals and 6 day surgeries. Prior to his appointment as CEO, Mr Sims was the Chief Operating Officer of Ramsay’s Australian and Asian operations since 1 July 2008. In this role, he was ultimately responsible for the operating performance and strategic directions of Ramsay’s hospital businesses in Australia, Indonesia and Malaysia.
Mr Sims started with Ramsay Health Care in 2003 after emigrating from the United States. He commenced with the Company as Group Financial Controller-Hospital Operations before moving to operational management as the New South Wales (NSW) State Operations Manager on 1 July 2006.
Prior to coming to Australia in 2003, Mr Sims was a health care financial executive for a variety of companies between 1990 to 2003, including Ramsay Health Care, Inc., a publicly-traded company specialising in inpatient and outpatient mental health treatment across the United States.
Prior to 1990, Mr. Sims worked as an auditor with Ernst & Young for nine years, specialising in audit services to hospitals.
Mr Sims has been a Board member of The Australian Private Hospital Association (APHA) since 2007. He is currently the Vice-President of the APHA and Chairman of the APHA Policy and Advocacy Task Force. Mr Sims is also a Board member of Ramsay Sime Darby Health Care.
Dr Leonie Katekar has over 25 years of health sector experience and is an accomplished, diversified and experienced health leadership executive. Dr Katekar has previously held roles as CEO Top End Division of General Practice, Director Remote Health Branch (Northern Territory) and national level leadership at NEHTA (National eHealth Transition Authority) as the Director of Clinical Leadership. In addition, Dr Katekar has worked on several boards including HealthDirect Australia, the Federal AMA and is currently a board director for East Melbourne PHN. Dr Katekar is now in a senior clinical leadership position at Medibank as the head of Clinical Engagement ant Medibank at Home.
Dr Benjamin Brady is a Medical Oncologist in the Skin and Melanoma Service at Peter Mac and also at Cabrini Health. He completed his Medical Oncology training at the Alfred, Royal Melbourne and Box Hill hospitals. Dr Brady spent many years in laboratory molecular biology at the Ludwig Institute for Cancer Research at the University of Melbourne and subsequently at the University of Colorado Health and Science Centre in Denver, CO, USA. Upon his return to Melbourne in 2002, he has been principal investigator and sub-investigator in many melanoma trials at Cabrini Health and Peter Mac. He has a large melanoma practice in the southeastern suburbs of Melbourne through to far East Gippsland. He is presently Craft Group Leader in Cancer Services at Cabrini Health.
First Assistant Secretary, Provider Benefits Integrity Division at Australian Department of Health
Simon Cotterell is the First Assistant Secretary of the Provider Benefits Integrity Division in the Department of Health. Simon has worked for over 28 years in government. Over the last 14 years in Health, Simon has led work on health payments integrity; global and regional health issues; drug policy; health financing; health security; the blood supply; organ and tissue donation; and a range of other health system issues.
Prior to Health, Simon worked for a decade as a policy adviser in the Department of the Prime Minister and Cabinet in various areas of social policy and international relations. Simon has qualifications in political science and economics, and was awarded a Public Service Medal in 2012 for his work on tobacco plain packaging and tobacco control in Aboriginal and Torres Strait Islander communities.
Dr Ian Irving graduated from the University of Queensland in 1991 with a Bachelor of Medicine and Bachelor of Surgery. He became a fellow of the Royal Australian College of Physicians in 2000 and of the Royal College of Pathologists of Australia in 2001. Dr Irving has previously been appointed in the public system as the director of haematology and bone marrow transplantation at the Townsville Hospital. From 2006 – 2013, he was the clinical director of the Institute of Cancer, during which time he was responsible for consolidating and expanding tertiary level cancer care in North Queensland.
His expertise covers a very broad range of haematological disorders, including bone marrow transplantation (autologous and allogeneic), acute leukaemia, lymphoma, obstetric haematology, general haematology, disorders of iron metabolism and laboratory haematology. This expertise comes from his extensive training and consultant posts in Brisbane, Perth and overseas in the positions of haematologist at Sullivan Nicolaides and St John of God Pathology, consultant haematologist at the Royal Brisbane Hospital, transplant physician (locum) at St James Hospital Dublin, consultant haematologist at National Maternity Hospital (Dublin), and haematologist at PathCentre WA.
Although retaining broad haematological knowledge, Dr Irving has a special clinical interest in lymphoma, myelodysplasia and myeloproliferative disorders. He has sat on national and international committees and advisory boards, focusing on haematological disorders such as chronic myeloid leukaemia, myelofibrosis, myelodysplasia, lymphoma and bone marrow transplantation.
Dr Irving is a strong advocate for clinical trial research, participating in phase I/II and III multicentre clinical trials. Dr Irving has many leadership qualities in addition to his clinical skills, having performed senior administrative roles in haematology and cancer.
Dr Ian Irving currently consults at Icon Wesley and Icon Mackay, and is Medical Director of Icon Group.